Early research (Phase 1)Study completedNCT04959981
What this trial is testing
Anti-Cancer Therapies Targeting the MAPK Pathway in Patients With Advanced NSCLC
Who this might be right for
Advanced Non-squamous Non-small-cell Lung Cancer
Erasca, Inc. 24